Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 21, Pages 5300
Publisher
MDPI AG
Online
2023-11-06
DOI
10.3390/cancers15215300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers
- (2023) Kholoud Alwosaibai et al. BMC CANCER
- The research status and prospects of MUC1 in immunology
- (2023) Linna Long et al. Human Vaccines & Immunotherapeutics
- Aptamers in cancer therapy: problems and new breakthroughs
- (2023) Baijiang Jin et al. Journal of Materials Chemistry B
- Recent progress of aptamer‒drug conjugates in cancer therapy
- (2023) Jiaxuan He et al. Acta Pharmaceutica Sinica B
- Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
- (2023) Sukanya Pati et al. Cancers
- Identification and Characterization of Aptamers Targeting Ovarian Cancer Biomarker Human Epididymis Protein 4 for the Application in Urine
- (2023) Antonija Hanžek et al. Cancers
- Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma
- (2023) Elizabeth A. Paris et al. Cancers
- Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma
- (2023) Mauricio Rocha Dourado et al. Frontiers in Oncology
- Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer
- (2023) Guozhen Deng et al. Frontiers in Bioengineering and Biotechnology
- Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
- (2023) Santosh K. Dasari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance
- (2023) Katarzyna Aneta Pankowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Next Generation of Ovarian Cancer Detection Using Aptamers
- (2023) Rayane da Silva Abreu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer
- (2023) María Castaño et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AXL in cancer: a modulator of drug resistance and therapeutic target
- (2023) Yaoxiang Tang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Aptamer-Based Targeted Delivery of Functional Nucleic Acids
- (2023) Sitao Xie et al. Journal of the American Chemical Society
- Single-cell transcriptomics in ovarian cancer identify a metastasis-associated cell cluster overexpressed RAB13
- (2023) Jiahao Guo et al. Journal of Translational Medicine
- Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L
- (2023) Christopher J. LaFargue et al. Nature Communications
- Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages
- (2023) Tingshan He et al. Journal of Ovarian Research
- Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors
- (2023) Laura Santana-Viera et al. Molecular Therapy-Nucleic Acids
- Computable structured aptamer for targeted treatment of ovarian cancer
- (2023) Luoshan Ruan et al. Frontiers in Genetics
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
- (2023) Iva Truxova et al. Journal for ImmunoTherapy of Cancer
- Macrophage CD5L is a target for cancer immunotherapy
- (2023) Lidia Sanchez-Moral et al. EBioMedicine
- Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis
- (2023) Jiyoung Kim et al. Cancers
- Galectin-3 and Epithelial MUC1 Mucin—Interactions Supporting Cancer Development
- (2023) Iwona Radziejewska Cancers
- HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances
- (2023) Kejia Zhao et al. Biomolecules
- Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics
- (2023) Sourav Chakraborty et al. Diagnostics
- Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
- (2023) Emine Bayraktar et al. Non-Coding RNA
- Self-Assembled Multivalent Aptamer Drug Conjugates: Enhanced Targeting and Cytotoxicity for HER2-Positive Gastric Cancer
- (2023) Wenjuan Ma et al. ACS Applied Materials & Interfaces
- Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
- (2023) Mehdi Sanati et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- CA125 Levels in BRCA mutation carriers – a retrospective single center cohort study
- (2023) P Gebhart et al. BMC CANCER
- A systematic review of emerging technologies to enhance the treatment of ovarian cancer
- (2023) Samaneh Sepahi et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Selection of DNA aptamer recognizing CD44 for high-efficiency capture of circulating tumor cells
- (2023) Tian Gao et al. TALANTA
- Recent Advancements of Aptamers in Cancer Therapy
- (2023) Swathi Venkatesan et al. ACS Omega
- Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment
- (2023) Anna Szymanowska et al. Non-Coding RNA
- Deglycosylated EpCAM regulates proliferation by enhancing autophagy of breast cancer cells via PI3K/Akt/mTOR pathway
- (2022) Liu Yang et al. Aging-US
- Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma
- (2022) Shuang Ye et al. BRITISH JOURNAL OF CANCER
- Ovarian cancer and KiSS-1 gene expression: A consideration of the use of Kisspeptin plus Kisspeptin aptamers in diagnostics and therapy
- (2022) Navinder Singh et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Drug delivery systems for RNA therapeutics
- (2022) Kalina Paunovska et al. NATURE REVIEWS GENETICS
- Progress in cancer drug delivery based on AS1411 oriented nanomaterials
- (2022) Xin Tong et al. JOURNAL OF NANOBIOTECHNOLOGY
- Spatially resolved transcriptomics of high-grade serous ovarian carcinoma
- (2022) Elaine Stur et al. iScience
- Targeted therapies for cancer
- (2022) Zhijun Zhou et al. BMC Medicine
- The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
- (2022) Iason Psilopatis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RNA-targeting and gene editing therapies for transthyretin amyloidosis
- (2022) Alberto Aimo et al. Nature Reviews Cardiology
- Therapeutic RNA-silencing oligonucleotides in metabolic diseases
- (2022) Algera Goga et al. NATURE REVIEWS DRUG DISCOVERY
- Single-cell dissection of the multiomic landscape of high-grade serous ovarian cancer
- (2022) Yicheng Wang et al. CANCER RESEARCH
- Aptamer‐siRNA chimeras: Promising tools for targeting HER2 signaling in cancer
- (2022) Chandrasekharan Rajalekshmi Dhanya et al. Chemical Biology & Drug Design
- The Functions of EphA1 receptor tyrosine kinase in Several Tumors.
- (2022) Yinxin Wu et al. CURRENT MEDICINAL CHEMISTRY
- Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer
- (2022) Adrian Dumitru et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma
- (2022) Elaine Stur et al. Cancers
- Expression of MUC1 in different tumours and its clinical significance (Review)
- (2022) Yue Lan et al. Molecular and Clinical Oncology
- Diagnostic accuracy of serum human epididymis protein 4 in ovarian cancer patients with different ethnic groups and menopausal status: a meta-analysis and systematic evaluation
- (2022) Rui Sun et al. Ginekologia Polska
- Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
- (2022) Yiyang Liu et al. Experimental Hematology & Oncology
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lumasiran: First Approval
- (2021) Lesley J. Scott et al. DRUGS
- Aptamer-Based Detection of Circulating Targets for Precision Medicine
- (2021) Lingling Wu et al. CHEMICAL REVIEWS
- Robust decomposition of cell type mixtures in spatial transcriptomics
- (2021) Dylan M. Cable et al. NATURE BIOTECHNOLOGY
- Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT
- (2021) Yao Zhao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity
- (2021) Paola Amero et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A homogeneous biosensor for Human Epididymis Protein 4 based on upconversion luminescence resonance energy transfer
- (2021) Xiuqing Ma et al. MICROCHEMICAL JOURNAL
- Insight Into the Prospects for RNAi Therapy of Cancer
- (2021) Zhili Tian et al. Frontiers in Pharmacology
- The current landscape of nucleic acid therapeutics
- (2021) Jayesh A. Kulkarni et al. Nature Nanotechnology
- Applications of Aptamers in the Diagnosis and Treatment of Ovarian Cancer: Progress From 2016 to 2020
- (2021) Luoshan Ruan et al. Frontiers in Genetics
- Breast Cancer Aptamers: Current Sensing Targets, Available Aptamers, and Their Evaluation for Clinical Use in Diagnostics
- (2021) Kathleen Varty et al. Cancers
- Cancer of the ovary, fallopian tube, and peritoneum: 2021 update
- (2021) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients
- (2021) Anna Pawłowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer
- (2021) Andrea M. Costello et al. MOLECULES
- Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells
- (2021) Agnieszka Gornowicz et al. MOLECULES
- Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
- (2021) Saima Usman et al. Cancers
- The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
- (2021) Arkan Youssef et al. Cancers
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications
- (2020) Baozhang Guan et al. International Journal of Nanomedicine
- AS1411 aptamer-functionalized chitosan-silica nanoparticles for targeted delivery of epigallocatechin gallate to the SKOV-3 ovarian cancer cell lines
- (2020) Leila Alizadeh et al. JOURNAL OF NANOPARTICLE RESEARCH
- Targeting Ephrin Receptor Tyrosine kinase A2 with a selective aptamer for glioblastoma stem cells
- (2020) Alessandra Affinito et al. Molecular Therapy-Nucleic Acids
- Aptamer-Functionalized DNA Nanostructures for Biological Applications
- (2020) Xiaoyi Fu et al. Topics in Current Chemistry
- HSP70 Multi-Functionality in Cancer
- (2020) Zarema Albakova et al. Cells
- Targeting tumor microenvironment in ovarian cancer: Premise and promise
- (2020) Yuting Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
- (2020) Sanghoon Lee et al. Cell Reports
- Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential
- (2020) Pranav Tripathi et al. Frontiers in Chemistry
- Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
- (2020) Shuaijian Ni et al. ACS Applied Materials & Interfaces
- Circular Bispecific Aptamer-Mediated Artificial Intercellular Recognition for Targeted T Cell Immunotherapy
- (2020) Yu Yang et al. ACS Nano
- Efficiency of nanoparticles for treatment of ocular infections: Systematic literature review
- (2020) Shahrzad Ghafoorianfar et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy
- (2020) Francesco Mainini et al. MOLECULES
- Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
- (2020) Innocenza Palaia et al. OncoTargets and Therapy
- Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy
- (2020) Yanfei Yang et al. Frontiers in Cell and Developmental Biology
- Signaling within the epithelial ovarian cancer tumor microenvironment: the challenge of tumor heterogeneity
- (2020) Max Horowitz et al. Annals of Translational Medicine
- EpCAM signaling promotes tumor progression and protein stability of PD-L1 through the EGFR pathway
- (2020) Hao-Nien Chen et al. CANCER RESEARCH
- Insight updating of the molecular hallmarks in ovarian carcinoma
- (2020) Alba Mota et al. EJC SUPPLEMENTS
- Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
- (2020) Keith T. Flaherty et al. JOURNAL OF CLINICAL ONCOLOGY
- A pathway map of AXL receptor-mediated signaling network
- (2020) Shobha Dagamajalu et al. Journal of Cell Communication and Signaling
- Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
- (2020) Paola Amero et al. Cancers
- Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer
- (2020) Abdelrahman M. Elsayed et al. Cancers
- EpCAM cellular functions in adhesion and migration, and potential impact on invasion: A critical review
- (2020) François Fagotto et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A review on development of MUC1-based cancer vaccine
- (2020) Tong Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
- (2020) Zhaoying Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CA125 and Ovarian Cancer: A Comprehensive Review
- (2020) Parsa Charkhchi et al. Cancers
- CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
- (2020) Antons Martincuks et al. Frontiers in Oncology
- Aptamer-Functionalized Exosomes: Elucidating the Cellular Uptake Mechanism and the Potential for Cancer-Targeted Chemotherapy
- (2019) Jianmei Zou et al. ANALYTICAL CHEMISTRY
- Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts
- (2019) Nicola Ferrari et al. Nature Communications
- siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer
- (2019) Christopher Halbur et al. SLAS Technology
- Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
- (2019) Vincent Dochez et al. Journal of Ovarian Research
- High tumor cell vimentin expression indicatesprolonged survival in patients with ovarian malignant tumors
- (2019) Sebastian Szubert et al. Ginekologia Polska
- Ovarian Cancer: An Integrated Review
- (2019) Christine Stewart et al. Seminars in Oncology Nursing
- Epithelial ovarian cancer: Evolution of management in the era of precision medicine
- (2019) Stephanie Lheureux et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
- (2019) San-Nung Chen et al. International Journal of Environmental Research and Public Health
- Modeling RNA-Binding Protein Specificity In Vivo by Precisely Registering Protein-RNA Crosslink Sites
- (2019) Huijuan Feng et al. MOLECULAR CELL
- The Hsp70 chaperone network
- (2019) Rina Rosenzweig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Stress-induced phosphoprotein 1 promotes pancreatic cancer progression through activation of the FAK/AKT/MMP signaling axis
- (2019) Yuanming Jing et al. PATHOLOGY RESEARCH AND PRACTICE
- CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1
- (2019) Jiayi Zhou et al. Frontiers in Oncology
- Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells
- (2019) Somayeh Vandghanooni et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Vimentin protects cells against nuclear rupture and DNA damage during migration
- (2019) Alison E. Patteson et al. JOURNAL OF CELL BIOLOGY
- Adipocytes promote ovarian cancer chemoresistance
- (2019) Jiang Yang et al. Scientific Reports
- Molecular characterization of endometrial cancer and therapeutic implications
- (2019) Boris Winterhoff et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum
- (2019) Selin Oncul et al. RNA Biology
- Aptamer (AS1411)-Conjugated Liposome for Enhanced Therapeutic Efficacy of miRNA-29b in Ovarian Cancer
- (2019) Lanyu Jiang et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Ultrasensitive flexible FET-type aptasensor for CA 125 cancer marker detection based on carboxylated multiwalled carbon nanotubes immobilized onto reduced graphene oxide film
- (2018) Samira Mansouri Majd et al. ANALYTICA CHIMICA ACTA
- Recent progresses in DNA nanostructure-based biosensors for detection of tumor markers
- (2018) Rongrong Huang et al. BIOSENSORS & BIOELECTRONICS
- Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer
- (2018) Melinda S. Yates et al. Cancer Prevention Research
- Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer
- (2018) Erfaneh Ghassami et al. International Journal of Nanomedicine
- Preparation, characterization and anti-proliferative effects of sclareol-loaded solid lipid nanoparticles on A549 human lung epithelial cancer cells
- (2018) Hamed Hamishehkar et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Implication of multivalent aptamers in DNA and DNA–RNA hybrid structures for efficient drug delivery in vitro and in vivo
- (2018) Yoon Young Kang et al. JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian Cancer Prevention and Screening
- (2018) Usha Menon et al. OBSTETRICS AND GYNECOLOGY
- Sensitive on-chip detection of cancer antigen 125 using a DNA aptamer/carbon nanotube network platform
- (2018) Vinayakumar Gedi et al. SENSORS AND ACTUATORS B-CHEMICAL
- Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
- (2018) Daniel J. McGrail et al. Nature Communications
- The role of microRNAs and nanoparticles in ovarian cancer: a review
- (2018) Leila Kafshdooz et al. Artificial Cells Nanomedicine and Biotechnology
- High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database
- (2018) Le Du et al. Biomed Research International
- Aptamer Therapeutics in Cancer: Current and Future
- (2018) Yoshihiro Morita et al. Cancers
- Aptamer-based targeted therapy
- (2018) Guizhi Zhu et al. ADVANCED DRUG DELIVERY REVIEWS
- Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells
- (2018) Xue Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis
- (2018) Shuai Yin et al. PATHOLOGY RESEARCH AND PRACTICE
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Getting TANned: How the tumor microenvironment drives neutrophil recruitment
- (2018) Shuvasree SenGupta et al. JOURNAL OF LEUKOCYTE BIOLOGY
- AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells
- (2018) Somayeh Vandghanooni et al. Nanomedicine
- Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
- (2018) Carla Esposito et al. Genes
- LncRNAs in ovarian cancer
- (2018) Jin-yan Wang et al. CLINICA CHIMICA ACTA
- Employing AgNPs doped amidoxime-modified polyacrylonitrile (PAN-oxime) nanofibers for target induced strand displacement-based electrochemical aptasensing of CA125 in ovarian cancer patients
- (2018) Leila Farzin et al. Materials Science & Engineering C-Materials for Biological Applications
- The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
- (2017) Chanitra Thuwajit et al. MEDICINAL RESEARCH REVIEWS
- An aptamer for recognizing the transmembrane protein PDL-1 (programmed death-ligand 1), and its application to fluorometric single cell detection of human ovarian carcinoma cells
- (2017) Rezvan Yazdian-Robati et al. MICROCHIMICA ACTA
- A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice
- (2017) Tal Gefen et al. MOLECULAR THERAPY
- RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery
- (2017) Fengmei Pi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Respective and simultaneous detection tumor markers CA125 and STIP1 using aptamer-based fluorescent and RLS sensors
- (2017) Feng Chen et al. SENSORS AND ACTUATORS B-CHEMICAL
- CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model
- (2017) Lisa Mayr et al. Oncotarget
- Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth
- (2017) Jingying Zheng et al. Theranostics
- Stable, polyvalent aptamer-conjugated near-infrared fluorescent nanocomposite for high-performance cancer cell-targeted imaging and therapy
- (2017) Yan-Jun Zhu et al. Journal of Materials Chemistry B
- Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer
- (2017) Rajesh Kotcherlakota et al. Journal of Materials Chemistry B
- Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
- (2017) Pinar Kanlikilicer et al. Molecular Therapy-Nucleic Acids
- Self-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery
- (2016) Wenshan Li et al. ACS Applied Materials & Interfaces
- Anti-angiogenic agents in ovarian cancer: past, present, and future
- (2016) B. J. Monk et al. ANNALS OF ONCOLOGY
- Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
- (2016) Weimin Wang et al. CELL
- Exosomes and tumor-mediated immune suppression
- (2016) Theresa L. Whiteside JOURNAL OF CLINICAL INVESTIGATION
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- Expression of preoperative KISS1 gene in tumor tissue with epithelial ovarian cancer and its prognostic value
- (2016) Fang Cao et al. MEDICINE
- In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing
- (2016) Ilaria Lamberti et al. METHODS
- Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications
- (2016) Mariya Vorobyeva et al. MOLECULES
- Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle
- (2016) Yao Chen et al. NANOTECHNOLOGY
- Roles of nucleolin. Focus on cancer and anti-cancer therapy
- (2016) Zhuo Chen et al. SAUDI MEDICAL JOURNAL
- MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
- (2016) Mario Martínez Soldevilla et al. Oncotarget
- Stress-induced phosphoprotein-1 maintains the stability of JAK2 in cancer cells
- (2016) Chia-Lung Tsai et al. Oncotarget
- Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
- (2015) Huiyuan Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- Selection of DNA aptamers for ovarian cancer biomarker HE4 using CE-SELEX and high-throughput sequencing
- (2015) Rachel M. Eaton et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer
- (2015) Chunbai He et al. BIOMATERIALS
- Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
- (2015) Jessica Gobbo et al. JNCI-Journal of the National Cancer Institute
- Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer
- (2015) G. Salzano et al. MOLECULAR CANCER THERAPEUTICS
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
- (2015) Jessica Gobbo et al. JNCI-Journal of the National Cancer Institute
- Identification of Cell Membrane Protein Stress-Induced Phosphoprotein 1 as a Potential Ovarian Cancer Biomarker Using Aptamers Selected by Cell Systematic Evolution of Ligands by Exponential Enrichment
- (2014) Dimitri Van Simaeys et al. ANALYTICAL CHEMISTRY
- Targeted therapy using nanotechnology: focus on cancer
- (2014) Mario Sechi et al. International Journal of Nanomedicine
- Hsp70 in cancer: back to the future
- (2014) M Y Sherman et al. ONCOGENE
- Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
- (2014) Hongguang Sun et al. Molecular Therapy-Nucleic Acids
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture
- (2013) Yanling Song et al. ANALYTICAL CHEMISTRY
- The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
- (2013) Junli Deng et al. CANCER AND METASTASIS REVIEWS
- Junctional Rab13-binding protein (JRAB) regulates cell spreading via filamins
- (2013) Ayuko Sakane et al. GENES TO CELLS
- The anti-chemoresistant effect and mechanism of MUC1 aptamer–miR-29b chimera in ovarian cancer
- (2013) Furong Dai et al. GYNECOLOGIC ONCOLOGY
- A HER2-targeted RNA aptamer molecule labeled with 99mTc for single-photon imaging in malignant tumors
- (2013) Kambiz Varmira et al. NUCLEAR MEDICINE AND BIOLOGY
- Tumor Stress-Induced Phosphoprotein1 (STIP1) as a Prognostic Biomarker in Ovarian Cancer
- (2013) Angel Chao et al. PLoS One
- In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker
- (2013) Nidaa Ababneh et al. Nucleic Acid Therapeutics
- Reversal of Paclitaxel Resistance in Epithelial Ovarian Carcinoma Cells by a MUC1 Aptamer-let-7i Chimera
- (2012) Nenghui Liu et al. CANCER INVESTIGATION
- Targeting Axl With an High-affinity Inhibitory Aptamer
- (2012) Laura Cerchia et al. MOLECULAR THERAPY
- Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
- (2012) Kristina W. Thiel et al. NUCLEIC ACIDS RESEARCH
- Anticancer role of MUC1 aptamer–miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation
- (2012) Furong Dai et al. Targeted Oncology
- Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy
- (2011) Anne-Laure Rérole et al. CANCER RESEARCH
- Chemical modification and design of anti-miRNA oligonucleotides
- (2011) K A Lennox et al. GENE THERAPY
- Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
- (2011) Ronak Savla et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced Gene Delivery and siRNA Silencing by Gold Nanoparticles Coated with Charge-Reversal Polyelectrolyte
- (2010) Shutao Guo et al. ACS Nano
- AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
- (2010) E. B. Rankin et al. CANCER RESEARCH
- Breaking down the barriers: siRNA delivery and endosome escape
- (2010) M. Dominska et al. JOURNAL OF CELL SCIENCE
- Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX
- (2010) Dimitri Van Simaeys et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started